All In Biotech

Drug Trial Radar · NCT05393804

A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Feasibility Trial of Autologous Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy Using Ide-Cel for Multiple Myeloma Patients Status Post Hematopoietic Cell Transplantation

Last checked: Nov 19, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

24

Actual

Start

May 20, 2022

Primary completion

May 2027

Study completion May 2027

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 26, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to see if the quality of T cells used to create ide-cel (bb2121) affects how ide-cel prevents cancer from coming back in people with relapsed or refractory multiple myeloma (MM), and who have had a hematopoietic cell transplant.

Conditions

  • Multiple Myeloma

Interventions

  • Ide-cel (bb2121)Biological

    Eligible patients will undergo leukapheresis, receive lymphodepleting (LD) chemotherapy followed by infusion of Ide-Cel or Cilta-Cel, and be monitored daily for 14 days, three times a week until day + 30 after CAR T infusion and monthly until 12 months post CAR T infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. feasibility of manufacturing Ide-Cel (to dose of at least 300 million cells)Time frame: 1 year

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

    Basking Ridge, New Jersey

  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

    Middletown, New Jersey

  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)

    Montvale, New Jersey

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)

    Commack, New York

  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Memorial Sloan Kettering Nassau (Limited Protocol Activities)

    Uniondale, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.